Always Remember - Buy The Dip

Sentiment Analysis For RTGN

The news is currently generally neutral for RTGN.

Based on TextBlob analysis of Yahoo! Finance news summaries for RTGN on 2015-08-05.

Yahoo! Finance News for RTGN

Ruthigen-Pulmatrix Merge, Focus on Respiratory Drugs - Analyst Blog
Ruthigen, Inc.RTGN and Pulmatrix, Inc. announced that they have entered into a definitive merger agreement on Mar 13, 2015. Upon closing of the transaction, Pulmatrix will become a wholly owned subsidiary of Ruthigen, which will be renamed as Pulmatrix.

Infection treatment biotech Ruthigen sets terms for $20 million IPO
Ruthigen, an early stage biotech developing therapeutics to prevent and treat infection in surgical procedures, announced terms for its IPO on Wednesday. The Santa Rosa, CA based company plans to raise $20 million by offering 1.5 million